"Benzoxazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
OXAZINES with a fused BENZENE ring.
| Descriptor ID |
D048588
|
| MeSH Number(s) |
D03.383.533.249 D03.633.100.209
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzoxazines".
Below are MeSH descriptors whose meaning is more specific than "Benzoxazines".
This graph shows the total number of publications written about "Benzoxazines" by people in this website by year, and whether "Benzoxazines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 9 | 9 | 18 |
| 2018 | 10 | 12 | 22 |
| 2019 | 3 | 4 | 7 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Benzoxazines" by people in Profiles.
-
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4+ T cell count. AIDS Res Ther. 2020 07 23; 17(1):46.
-
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol Res. 2020 09; 159:104960.
-
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances. AIDS. 2020 01 01; 34(1):53-61.
-
Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.
-
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients. Infect Dis (Lond). 2019 08; 51(8):615-617.
-
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity. Mol Genet Genomic Med. 2019 04; 7(4):e00598.
-
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors. Int J Antimicrob Agents. 2019 Apr; 53(4):515-519.
-
Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study. Lancet HIV. 2019 04; 6(4):e250-e258.
-
Should efavirenz be used in children and, if so, how? Lancet HIV. 2019 04; 6(4):e210-e211.
-
Effects of baseline symptom burden on treatment response in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:181-194.